A92 ANTI-TNF DOSE AUGMENTATION FREQUENTLY OCCURS IN THE ABSENCE OF OBJECTIVE EVIDENCE OF DISEASE ACTIVITY

BACKGROUND: Anti tumor necrosis factor therapy (anti-TNF) is widely used in patients with moderate to severe CD and UC. When symptoms persist, anti-TNF dose is often increased or the dosing interval shortened. Evidence supporting the effectiveness of dose augmentation is of low quality and dose augm...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Can Assoc Gastroenterol
Hauptverfasser: Elias, E, Oketola, A, Bernstein, C N, Singh, H, Targownik, L
Format: Artigo
Sprache:Inglês
Veröffentlicht: Oxford University Press 2018
Schlagworte:
Paper Sessions
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6508157/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jcag/gwy009.092
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge